Feige Filling will be introducing Integra 86, a fully automated filling system which offers enhanced performance and safety while significantly reducing the energy input.

The aim of the ‘Macbeth’ project is to develop a new process for catalytic synthesis with appropriate separation equipment in a single, highly efficient catalytic membrane reactor. The project brings together 24 partners with expertise in the field. The EU has offered around 18 million dollars for this project.

Quattroflow has recently announced that it has extended its line of multiple- and single-use pumps with the introduction of the new QF2500 Quaternary Diaphragm Pump. With a maximum flow rate of 2,500 lph (660 gph), the new pump is ideally suited to meet the needs within demanding biopharma applications, including chromatography, TFF, virus filtration, sterile filtration, and depth filtration.

Sumitomo Chemical has plans to strengthen the development and quality assurance system for photoresists for EUV lithography and other advanced semiconductor processes due to the growing demand of photoresists in the market.

With an aim to take this project forward, Linde will invest 1.4 billion dollars to expand its present gasification complex and integrate it with Exxon Mobil's multi-billion dollar expansion project. Under the long term agreement, Linde will produce and supply additional hydrogen and synthesis gas to the complex.

Water treatment and purification is a technologically demanding process. Dosing is a core task here: Additives and auxiliary agents or highly effective chemicals need to be added both cost-effectively and safely for the environment, which means that the requirements for dosing pumps are just as high. Digitalization is the order of the day here as well.

The new drug Sevenfact can be used as an additional treatment option for adults and adolescents suffering from hemophilia A or B and inhibitors. The drug comprising an active ingredient from genetically engineered rabbits produces a protein necessary for blood coagulation and is claimed to be the first of its kind to treat hemophilia.

The new software saves time with functionality, modelling and data pre-processing. It also makes model data easier to interpret for better process control and mines data to help optimise product quality, resource use and cost efficiency.

Patent pending Safe Dock is a new user-friendly system to fill or empty containers such as big bags or sacks. With the ever increasing importance of occupational health requirements and safe production standards, high containment operation has become a must. That is exactly what the revolutionary Safe Dock provides among various other advantages.

Cambrex’s plant is located at Durham in North Carolina and has now completed expansion of its biopharmaceutical analysis capabilities. Post this, the site now features a range of new instruments used in the specialised industry.